347 related articles for article (PubMed ID: 20801085)
1. Treatment of Duchenne muscular dystrophy with ciclosporin A: a randomised, double-blind, placebo-controlled multicentre trial.
Kirschner J; Schessl J; Schara U; Reitter B; Stettner GM; Hobbiebrunken E; Wilichowski E; Bernert G; Weiss S; Stehling F; Wiegand G; Müller-Felber W; Thiele S; Grieben U; von der Hagen M; Lütschg J; Schmoor C; Ihorst G; Korinthenberg R
Lancet Neurol; 2010 Nov; 9(11):1053-9. PubMed ID: 20801085
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Mercuri E; Vilchez JJ; Boespflug-Tanguy O; Zaidman CM; Mah JK; Goemans N; Müller-Felber W; Niks EH; Schara-Schmidt U; Bertini E; Comi GP; Mathews KD; Servais L; Vandenborne K; Johannsen J; Messina S; Spinty S; McAdam L; Selby K; Byrne B; Laverty CG; Carroll K; Zardi G; Cazzaniga S; Coceani N; Bettica P; McDonald CM;
Lancet Neurol; 2024 Apr; 23(4):393-403. PubMed ID: 38508835
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of tamoxifen in boys with Duchenne muscular dystrophy (TAMDMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Henzi BC; Schmidt S; Nagy S; Rubino-Nacht D; Schaedelin S; Putananickal N; Stimpson G; ; Amthor H; Childs AM; Deconinck N; de Groot I; Horrocks I; Houwen-van Opstal S; Laugel V; Lopez Lobato M; Madruga Garrido M; Nascimento Osorio A; Schara-Schmidt U; Spinty S; von Moers A; Lawrence F; Hafner P; Dorchies OM; Fischer D
Lancet Neurol; 2023 Oct; 22(10):890-899. PubMed ID: 37739572
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial.
Buyse GM; Voit T; Schara U; Straathof CSM; D'Angelo MG; Bernert G; Cuisset JM; Finkel RS; Goemans N; McDonald CM; Rummey C; Meier T;
Lancet; 2015 May; 385(9979):1748-1757. PubMed ID: 25907158
[TBL] [Abstract][Full Text] [Related]
5. Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
McDonald CM; Campbell C; Torricelli RE; Finkel RS; Flanigan KM; Goemans N; Heydemann P; Kaminska A; Kirschner J; Muntoni F; Osorio AN; Schara U; Sejersen T; Shieh PB; Sweeney HL; Topaloglu H; Tulinius M; Vilchez JJ; Voit T; Wong B; Elfring G; Kroger H; Luo X; McIntosh J; Ong T; Riebling P; Souza M; Spiegel RJ; Peltz SW; Mercuri E; ;
Lancet; 2017 Sep; 390(10101):1489-1498. PubMed ID: 28728956
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
Manzur AY; Kuntzer T; Pike M; Swan A
Cochrane Database Syst Rev; 2008 Jan; (1):CD003725. PubMed ID: 18254031
[TBL] [Abstract][Full Text] [Related]
7. Intermittent prednisone therapy in Duchenne muscular dystrophy: a randomized controlled trial.
Beenakker EA; Fock JM; Van Tol MJ; Maurits NM; Koopman HM; Brouwer OF; Van der Hoeven JH
Arch Neurol; 2005 Jan; 62(1):128-32. PubMed ID: 15642859
[TBL] [Abstract][Full Text] [Related]
8. Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
McDonald CM; Marbán E; Hendrix S; Hogan N; Ruckdeschel Smith R; Eagle M; Finkel RS; Tian C; Janas J; Harmelink MM; Varadhachary AS; Taylor MD; Hor KN; Mayer OH; Henricson EK; Furlong P; Ascheim DD; Rogy S; Williams P; Marbán L;
Lancet; 2022 Mar; 399(10329):1049-1058. PubMed ID: 35279258
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
Manzur AY; Kuntzer T; Pike M; Swan A
Cochrane Database Syst Rev; 2004; (2):CD003725. PubMed ID: 15106215
[TBL] [Abstract][Full Text] [Related]
10. Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial.
Raman SV; Hor KN; Mazur W; Halnon NJ; Kissel JT; He X; Tran T; Smart S; McCarthy B; Taylor MD; Jefferies JL; Rafael-Fortney JA; Lowe J; Roble SL; Cripe LH
Lancet Neurol; 2015 Feb; 14(2):153-61. PubMed ID: 25554404
[TBL] [Abstract][Full Text] [Related]
11. Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial.
Ravnborg M; Sørensen PS; Andersson M; Celius EG; Jongen PJ; Elovaara I; Bartholomé E; Constantinescu CS; Beer K; Garde E; Sperling B
Lancet Neurol; 2010 Jul; 9(7):672-80. PubMed ID: 20542736
[TBL] [Abstract][Full Text] [Related]
12. Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.
Guglieri M; Bushby K; McDermott MP; Hart KA; Tawil R; Martens WB; Herr BE; McColl E; Speed C; Wilkinson J; Kirschner J; King WM; Eagle M; Brown MW; Willis T; Griggs RC; ; Straub V; van Ruiten H; Childs AM; Ciafaloni E; Shieh PB; Spinty S; Maggi L; Baranello G; Butterfield RJ; Horrocks IA; Roper H; Alhaswani Z; Flanigan KM; Kuntz NL; Manzur A; Darras BT; Kang PB; Morrison L; Krzesniak-Swinarska M; Mah JK; Mongini TE; Ricci F; von der Hagen M; Finkel RS; O'Reardon K; Wicklund M; Kumar A; McDonald CM; Han JJ; Joyce N; Henricson EK; Schara-Schmidt U; Gangfuss A; Wilichowski E; Barohn RJ; Statland JM; Campbell C; Vita G; Vita GL; Howard JF; Hughes I; McMillan HJ; Pegoraro E; Bello L; Burnette WB; Thangarajh M; Chang T
JAMA; 2022 Apr; 327(15):1456-1468. PubMed ID: 35381069
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trial.
Nagy S; Hafner P; Schmidt S; Rubino-Nacht D; Schädelin S; Bieri O; Fischer D
Trials; 2019 Nov; 20(1):637. PubMed ID: 31752977
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study.
Voit T; Topaloglu H; Straub V; Muntoni F; Deconinck N; Campion G; De Kimpe SJ; Eagle M; Guglieri M; Hood S; Liefaard L; Lourbakos A; Morgan A; Nakielny J; Quarcoo N; Ricotti V; Rolfe K; Servais L; Wardell C; Wilson R; Wright P; Kraus JE
Lancet Neurol; 2014 Oct; 13(10):987-96. PubMed ID: 25209738
[TBL] [Abstract][Full Text] [Related]
15. CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy.
Escolar DM; Buyse G; Henricson E; Leshner R; Florence J; Mayhew J; Tesi-Rocha C; Gorni K; Pasquali L; Patel KM; McCarter R; Huang J; Mayhew T; Bertorini T; Carlo J; Connolly AM; Clemens PR; Goemans N; Iannaccone ST; Igarashi M; Nevo Y; Pestronk A; Subramony SH; Vedanarayanan VV; Wessel H;
Ann Neurol; 2005 Jul; 58(1):151-5. PubMed ID: 15984021
[TBL] [Abstract][Full Text] [Related]
16. Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial.
Hafner P; Bonati U; Rubino D; Gocheva V; Zumbrunn T; Gueven N; Fischer D
Trials; 2016 Aug; 17(1):389. PubMed ID: 27488051
[TBL] [Abstract][Full Text] [Related]
17. Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: results from a 12 month, double-blind, randomized placebo-controlled trial.
Buyse GM; Goemans N; van den Hauwe M; Thijs D; de Groot IJ; Schara U; Ceulemans B; Meier T; Mertens L
Neuromuscul Disord; 2011 Jun; 21(6):396-405. PubMed ID: 21435876
[TBL] [Abstract][Full Text] [Related]
18. Effect of creatine monohydrate in improving cellular energetics and muscle strength in ambulatory Duchenne muscular dystrophy patients: a randomized, placebo-controlled 31P MRS study.
Banerjee B; Sharma U; Balasubramanian K; Kalaivani M; Kalra V; Jagannathan NR
Magn Reson Imaging; 2010 Jun; 28(5):698-707. PubMed ID: 20395096
[TBL] [Abstract][Full Text] [Related]
19. Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy.
Duboc D; Meune C; Lerebours G; Devaux JY; Vaksmann G; Bécane HM
J Am Coll Cardiol; 2005 Mar; 45(6):855-7. PubMed ID: 15766818
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy.
Griggs RC; Miller JP; Greenberg CR; Fehlings DL; Pestronk A; Mendell JR; Moxley RT; King W; Kissel JT; Cwik V; Vanasse M; Florence JM; Pandya S; Dubow JS; Meyer JM
Neurology; 2016 Nov; 87(20):2123-2131. PubMed ID: 27566742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
